BMS303141
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | BMS303141 is a potent inhibitor of ATP citrate lyase (ACL). BMS303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model. |
---|
Catalog Num | A13807 |
---|---|
Formula | C19H15Cl2NO4S |
Molecular Weight | 424.3 |
CAS Number | 943962-47-8 |
SMILES | COC1=C(C=C(C=C1)C2=CC=CC=C2)NS(=O)(=O)C3=CC(=CC(=C3O)Cl)Cl |
Synonyms | BMS 303141, BMS-303141 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 73 mg/mL (172.04 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.57 mL | 117.84 mL | 235.68 mL |
0.5 mM | 4.71 mL | 23.57 mL | 47.14 mL |
1 mM | 2.36 mL | 11.78 mL | 23.57 mL |
5 mM | 0.47 mL | 2.36 mL | 4.71 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2